-
The FDA issued a conditional approval for Strattera on Aug. 14 but said that some new clinical studies might be needed to get the drug on the market.
FORBES: Magazine Article
-
More than 50% of the value of Savient shares has been added since June 12, when scientists at the FDA issued early findings that seemed to favor approval for Krystexxa, and June 16, when a panel of outside scientists picked by the FDA voted that Krystexxa should be approved.
FORBES: Drugs
-
While both countries have signalled their willingness to sign the deal, they still need parliamentary approval which is now at risk after Swiss prosecutors on Saturday issued arrest warrants for three German tax inspectors from the state of North Rhine-Westphalia.
FORBES: Switzerland to Attempt to Arrest German Tax Collectors